Octant Bio

OverviewSuggest Edit

Octant Bio is a company developing a multiplexed technology that uses synthetic biology, genome engineering, sequencing, and computational tools to simultaneously measure the activity of receptor pathways in human cells. By linking receptor activity to genetic barcodes in a pooled fashion, it screens small-molecule libraries against comprehensive sets of drug targets. The company applies machine learning methods to engineer small molecules that interact with multiple receptors and therefore treat diseases.

Latest Updates

Employees (est.) (Sept 2021)38(+3%)
Cybersecurity ratingAMore

Key People/Management at Octant Bio

Jason Kelly

Jason Kelly

Ramsey Homsany

Ramsey Homsany

Co-founder & President, Director
Sri Kosuri

Sri Kosuri

Cofounder and CEO
Jorge Conde

Jorge Conde

Show more

Octant Bio Financials and Metrics

Summary Metrics

Founding Date


Octant Bio total Funding

$35 m

Octant Bio latest funding size

$30 m

Time since last funding

a year ago

Octant Bio investors

Octant Bio's latest funding round in May 2020 was reported to be $30 m. In total, Octant Bio has raised $35 m
Show all financial metrics

Octant Bio Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Octant Bio Online and Social Media Presence

Embed Graph

Octant Bio Frequently Asked Questions

  • When was Octant Bio founded?

    Octant Bio was founded in 2017.

  • Who are Octant Bio key executives?

    Octant Bio's key executives are Jason Kelly, Ramsey Homsany and Sri Kosuri.

  • How many employees does Octant Bio have?

    Octant Bio has 38 employees.

  • Who are Octant Bio competitors?

    Competitors of Octant Bio include MiroBio, Phylagen and Renaissance BioScience.